John B Sotomayor

Array ( [id] => 1467497 [patent_doc_number] => 06458850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications' [patent_app_type] => B1 [patent_app_number] => 09/466413 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13027 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458850.pdf [firstpage_image] =>[orig_patent_app_number] => 09466413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1467505 [patent_doc_number] => 06458851 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-01 [patent_title] => 'Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications' [patent_app_type] => B1 [patent_app_number] => 09/466415 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16194 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/458/06458851.pdf [firstpage_image] =>[orig_patent_app_number] => 09466415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454208 [patent_doc_number] => 06462091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications' [patent_app_type] => B1 [patent_app_number] => 09/466414 [patent_app_country] => US [patent_app_date] => 1999-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12025 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462091.pdf [firstpage_image] =>[orig_patent_app_number] => 09466414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494737 [patent_doc_number] => 06342533 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Derivatives of ()-venlafaxine and methods of preparing and using the same' [patent_app_type] => B1 [patent_app_number] => 09/450690 [patent_app_country] => US [patent_app_date] => 1999-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12280 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342533.pdf [firstpage_image] =>[orig_patent_app_number] => 09450690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470178 [patent_doc_number] => 06407077 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => '-L nucleosides for the treatment of HIV infection' [patent_app_type] => B1 [patent_app_number] => 09/435268 [patent_app_country] => US [patent_app_date] => 1999-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14604 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407077.pdf [firstpage_image] =>[orig_patent_app_number] => 09435268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4380433 [patent_doc_number] => 06303624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Preventives and remedies for hyperphosphatemia' [patent_app_type] => 1 [patent_app_number] => 9/380617 [patent_app_country] => US [patent_app_date] => 1999-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8839 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303624.pdf [firstpage_image] =>[orig_patent_app_number] => 380617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1457864 [patent_doc_number] => 06391334 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Barrier-forming composition' [patent_app_type] => B1 [patent_app_number] => 09/426428 [patent_app_country] => US [patent_app_date] => 1999-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1973 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/391/06391334.pdf [firstpage_image] =>[orig_patent_app_number] => 09426428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495769 [patent_doc_number] => 06403657 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Comprehensive pharmacologic therapy for treatment of obesity' [patent_app_type] => B1 [patent_app_number] => 09/412701 [patent_app_country] => US [patent_app_date] => 1999-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5416 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403657.pdf [firstpage_image] =>[orig_patent_app_number] => 09412701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4363335 [patent_doc_number] => 06287586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Pharmaceutical compositions of vanadium biguanide complexes and their use' [patent_app_type] => 1 [patent_app_number] => 9/396982 [patent_app_country] => US [patent_app_date] => 1999-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287586.pdf [firstpage_image] =>[orig_patent_app_number] => 396982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1521315 [patent_doc_number] => 06414012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof' [patent_app_type] => B1 [patent_app_number] => 09/373163 [patent_app_country] => US [patent_app_date] => 1999-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10620 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 890 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/414/06414012.pdf [firstpage_image] =>[orig_patent_app_number] => 09373163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418485 [patent_doc_number] => 06518317 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Antiviral agents' [patent_app_type] => B1 [patent_app_number] => 09/367185 [patent_app_country] => US [patent_app_date] => 1999-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13543 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518317.pdf [firstpage_image] =>[orig_patent_app_number] => 09367185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636396 [patent_doc_number] => 06380263 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => '6-substituted pyrimidine 3-oxides for promoting pigmentation of the skin/hair' [patent_app_type] => B1 [patent_app_number] => 08/931890 [patent_app_country] => US [patent_app_date] => 1997-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4122 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380263.pdf [firstpage_image] =>[orig_patent_app_number] => 08931890 [rel_patent_id] =>[rel_patent_doc_number] =>)